Want to see TSE:UDOC full AI Analyst Report?

UniDoc Health Corp (UDOC) Ratios

69 Followers

UniDoc Health Corp Ratios

TSE:UDOC's free cash flow for Q4 2026 was C$0.09. For the 2026 fiscal year, TSE:UDOC's free cash flow was decreased by C$ and operating cash flow was C$-4.23. See a summary of the company’s cash flow.

Ratios	TTM	Jun 26	Jun 25	Jun 24	Jun 22
Liquidity Ratios
Current Ratio	―	0.33	0.99	0.21	1.50
Quick Ratio	―	0.33	0.99	0.19	1.50
Cash Ratio	―	0.11	0.61	0.17	1.28
Solvency Ratio	―	-1.17	-2.69	-0.92	-4.14
Operating Cash Flow Ratio	―	-0.96	-3.58	-0.24	-3.58
Short-Term Operating Cash Flow Coverage	―	-88.36	-523.03	-16.00	-96.41
Net Current Asset Value	C$ ―	C$ -1.81M	C$ -194.45K	C$ -1.90M	C$ 281.70K
Leverage Ratios
Debt-to-Assets Ratio	―	0.02	0.02	0.14	0.07
Debt-to-Equity Ratio	―	-0.03	0.10	-0.04	0.17
Debt-to-Capital Ratio	―	-0.03	0.09	-0.04	0.15
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	>-0.01	0.00
Financial Leverage Ratio	―	-1.49	4.37	-0.28	2.58
Debt Service Coverage Ratio	―	-89.87	-52.52	-49.98	-112.66
Interest Coverage Ratio	―	-500.19	-58.70	-253.68	-1.70K
Debt to Market Cap	―	<0.01	<0.01	<0.01	0.06
Interest Debt Per Share	―	<0.01	<0.01	<0.01	<0.01
Net Debt to EBITDA	―	0.08	0.20	0.15	0.26
Profitability Margins
Gross Profit Margin	―	7.02%	0.00%	0.00%	0.00%
EBIT Margin	―	-331.94%	0.00%	0.00%	0.00%
EBITDA Margin	―	-312.50%	0.00%	0.00%	0.00%
Operating Profit Margin	―	-331.94%	0.00%	0.00%	0.00%
Pretax Profit Margin	―	-344.74%	0.00%	0.00%	0.00%
Net Profit Margin	―	-344.74%	0.00%	0.00%	0.00%
Continuous Operations Profit Margin	―	-344.74%	0.00%	0.00%	0.00%
Net Income Per EBT	―	100.00%	100.00%	100.00%	100.00%
EBT Per EBIT	―	103.86%	104.65%	102.69%	100.07%
Return on Assets (ROA)	―	-207.61%	-208.69%	-437.04%	-255.11%
Return on Equity (ROE)	―	310.08%	-912.45%	121.28%	-658.58%
Return on Capital Employed (ROCE)	―	362.24%	-690.18%	118.96%	-587.88%
Return on Invested Capital (ROIC)	―	373.71%	-657.08%	123.04%	-535.95%
Return on Tangible Assets	―	-359.35%	-288.13%	-437.04%	-255.11%
Earnings Yield	―	-34.87%	-32.42%	-10.20%	-758.18%
Efficiency Ratios
Receivables Turnover	―	3.50	0.00	0.00	0.00
Payables Turnover	―	0.46	0.03	0.04	0.04
Inventory Turnover	―	0.00	0.00	2.11	0.00
Fixed Asset Turnover	―	8.46	0.00	0.00	0.00
Asset Turnover	―	0.60	0.00	0.00	0.00
Working Capital Turnover Ratio	―	-1.14	0.00	0.00	0.00
Cash Conversion Cycle	―	-683.54	-13.13K	-8.74K	-8.61K
Days of Sales Outstanding	―	104.24	0.00	0.00	0.00
Days of Inventory Outstanding	―	0.00	0.00	172.95	0.00
Days of Payables Outstanding	―	787.77	13.13K	8.92K	8.61K
Operating Cycle	―	104.24	0.00	172.95	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.03	-0.13	-0.01	-0.11
Free Cash Flow Per Share	―	-0.03	-0.14	-0.01	-0.11
CapEx Per Share	―	<0.01	<0.01	0.00	<0.01
Free Cash Flow to Operating Cash Flow	―	1.03	1.03	1.00	1.02
Dividend Paid and CapEx Coverage Ratio	―	-32.69	-28.70	0.00	-46.57
Capital Expenditure Coverage Ratio	―	-32.69	-28.70	0.00	-46.57
Operating Cash Flow Coverage Ratio	―	-88.36	-107.71	-7.48	-30.10
Operating Cash Flow to Sales Ratio	―	-2.49	0.00	0.00	0.00
Free Cash Flow Yield	―	-25.92%	-40.94%	-2.53%	-614.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-2.87	-3.05	-9.80	-0.13
Price-to-Sales (P/S) Ratio	―	9.89	0.00	0.00	0.00
Price-to-Book (P/B) Ratio	―	-8.89	28.14	-11.89	0.87
Price-to-Free Cash Flow (P/FCF) Ratio	―	-3.86	-2.44	-39.56	-0.16
Price-to-Operating Cash Flow Ratio	―	-3.98	-2.53	-39.56	-0.17
Price-to-Earnings Growth (PEG) Ratio	―	0.05	-0.02	0.35	>-0.01
Enterprise Value Multiple	―	-3.08	-2.96	-10.00	0.13
Enterprise Value	―	9.02M	17.52M	21.83M	-378.81K
EV to EBITDA	―	-3.08	-2.96	-10.00	0.13
EV to Sales	―	9.62	0.00	0.00	0.00
EV to Free Cash Flow	―	-3.76	-2.29	-38.98	0.16
EV to Operating Cash Flow	―	-3.87	-2.37	-38.98	0.16
Tangible Book Value Per Share	―	-0.02	>-0.01	-0.04	0.02
Shareholders’ Equity Per Share	―	-0.01	0.01	-0.04	0.02
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	0.00
Revenue Per Share	―	0.01	0.00	0.00	0.00
Net Income Per Share	―	-0.04	-0.11	-0.04	-0.14
Tax Burden	―	1.00	1.00	1.00	1.00
Interest Burden	―	1.04	1.02	1.00	1.00
Research & Development to Revenue	―	<0.01	0.00	0.00	0.00
SG&A to Revenue	―	3.38	0.00	0.00	0.00
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.72	1.22	0.25	0.79

Currency in CAD